Acidic insulin preparations with improved stability

Details for Australian Patent Application No. 2003238471 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Lill, Norbert; Brunner-Schwarz, Anette

Agent Watermark

Pub. Number AU-B-2003238471

PCT Number PCT/EP03/05887

PCT Pub. Number WO2003/105888

Priority 102 27 232.8 18.06.02 DE

Filing date 5 June 2003

Wipo publication date 31 December 2003

Acceptance publication date 19 February 2009

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61K 45/08 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/04 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/08 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing oxygen

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/14 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Esters of carboxylic acids

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/42 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Proteins

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): 102 27 232.8 18.06.02 DE

26 February 2004 Application Open to Public Inspection

  Published as AU-B-2003238471

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

19 February 2009 Application Accepted

  Published as AU-B-2003238471

18 June 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003238472-3-SUBSTITUTED 4-HYDROXY-4-AMINOMETHYL-PIPE RIDINES

2003238470-GEARBOX